The mutations of EP300 in cancer encompass microdeletions, truncating mutations, and point mutations in different domains [120] and occurred in 30 of 379 ENKTL cases (7.9%) examined by NGS [87,88,91]. The gene discussed is EP300; the disease is cancer.